Ocular hypotensive efficacy and safety of once daily carteolol alginate

British Journal of Ophthalmology

Volumn 85, Issue 8, 2001, Pages 921-924

  Demailly, P ^a   Allaire, C ^b   Trinquand, C ^b  

^a SAINT JOSEPH HOSPITAL   (France)

^b Laboratoire Chauvin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CARTEOLOL; CARTEOLOL ALGINATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EYE IRRITATION; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PUNCTATE KERATITIS; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA DEGENERATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ALGINATES; ANALYSIS OF VARIANCE; CARTEOLOL; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA, OPEN-ANGLE; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; INSTILLATION, DRUG; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; STATISTICS, NONPARAMETRIC; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELDS;

EID: 0034906237     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.85.8.921     Document Type: Article

References (16)

1. Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for clinical use
2. Carteolol hydrochloride: Controlled evaluations of its ocular hypotensive efficacy relative to its vehicle, and, in combination with pilocarpine, relative to timolol
3. A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma
4. Influence of carteolol and timolol on IOP an visual fields in glaucoma: A multi-center, double-masked, prospective study
5. Treatment adherence
6. Mucilaginous substances from macroalgae: An overview
7. Patterns of food and acid reflux in patients with low-grade oesophagitis - The role of an anti-reflux agent
8. A new long acting ophthalmic formulation of carteolol containing alginic acid
9. The intraocular pressure lowering effect of timolol in gel-forming solution
10. Essais d'équivalence: Méthodologie et analyse
11. Carteolol, an ophthalmic β-adrenergic blocker with intrinsic sympathomimetic activity
12. Measuring drug-induced eye irritation: A simple new clinical assay
13. A double-masked comparison of carteolol and timolol in ocular hypertension
14. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma
15. The toxicity of topical ophthalmic beta-blockers
16. Ophthalmic topical beta blockers: Review of ocular and systemic adverse effects